First Generic HIV/AIDS Capsule

Generic HIV

Aurobindo Pharma’s zidovudine, the first generic capsule dosage form to treat HIV/AIDS, is now approved for patients in the U.S. The tablet and oral solution dosage forms of generic zidovudine were previously approved for sale in the U.S. when the patent on those dosage forms expired in September 2005.

The approval of the capsule formulation follows the expiration of Glaxo-SmithKline’s patent on its capsule form of the product marketed under the trade name Canadian Retrovir.